BioSpace News Archive

Venture Firm Wellington Partners Launches $237 Million Life Science Fund

The fund plans to build a portfolio of about 15 to 20 companies, with a focus on novel biotechnology platforms, new therapeutics and medical devices, as well as diagnostics and digital medicine.

July 31, 2019
·
2 min read
·
Mark Terry
Business

Charles River Labs to Launch Bay Area CRADL Facility in 2020

Charles River Labs will open its CRADL facility in South San Francisco in January 2020 in order to provide flexible, turnkey vivarium rental space for startups.

July 31, 2019
·
4 min read
·
Mark Terry and Alex Keown
Alligator Plans Phase II Trial of Immunotherapy Compound After Regaining Rights from Janssen

The product was originally licensed in a partnership deal in 2015, which has now been terminated in what is being called a strategic portfolio decision by Janssen.

July 31, 2019
·
2 min read
·
Mark Terry
Business

RegenxBio and Pfizer Partner on Gene Therapy for Friedreich’s Ataxia

Under the terms of the deal, RegenxBio granted Pfizer a non-exclusive global license, with rights to sublicense, RegenxBio’s NAV AAV9 vector. In return, Pfizer is paying RegenxBio an upfront payment, various milestones and royalties on net sales.

July 31, 2019
·
2 min read
·
Mark Terry
Deals

Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate

Proceeds will be used to grow company’s team in Lyon and Boston, to advance its current programs in hypoparathyroidism and severe insulin resistance into clinical development, and to further strengthen its product portfolio in rare endocrine and metabolic diseases

July 31, 2019
·
8 min read
Deals

Catalyst Pharmaceuticals to Hold Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 8th, 2019

Catalyst Pharmaceuticals, Inc. announced that it will release second quarter 2019 financial result after market close on Wednesday, August 7, 2019.

July 31, 2019
·
2 min read
Business

VMS BioMarketing Announces Appointment of Brion Brandes as SVP of Business Development

Attracting Top Talent Will Enable VMS to Continue Expanding Its Clinical Nurse Educator Programs to Help More Patients Served by the Biopharma Industry

July 31, 2019
·
2 min read
Deals

Esperion to Report Second Quarter 2019 Financial Results August 8, 2019

Esperion announced it will report second quarter 2019 financial results on August 8, 2019 before the U.S. financial markets open.

July 31, 2019
·
5 min read
FDA

Bayer’s Prostate Cancer Drug Earns FDA Approval

The U.S. Food and Drug Administration approved Bayer’s Nubeqa (darolutamide) for non-metastatic castration-resistant prostate cancer.

July 31, 2019
·
2 min read
·
Mark Terry
Business

Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease using Clinical Artificial Intelligence

First major drug development agreement signed by Sensyne Health since IPO with potential for expansion

July 31, 2019
·
3 min read